Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Apr 2014

Lu Zheng-mao, Luo Tian-hang, Nie Ming-ming, Fang Guo-en, Ma Li-ye, Xue Xu-chao, Wei Guo, Ke Chong-we, Bi Jian-wei

Abstract excerpt

Polymorphisms in the excision repair cross-complimentary group 1 (ERCC1)-excision repair cross-complimentary group 4 (ERCC4) genes have been implicated in the prognosis of various cancers. We conducted a cohort study to investigate the role of ERCC1-ERCC4 gene polymorphisms on the response to chemotherapy and the role of these two gene polymorphisms on the clinical outcomes of gastric cancer. Four hundred...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to DNA Repair

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endonucleases

Share to Fluorouracil

Share to Leucovorin

Share to Organoplatinum Compounds

Share to Proportional Hazards Models

Share to Stomach Neoplasms

Source

Identifiers

PMID: 24318989
DOI: 10.1007/s13277-013-1378-7

Genes

ERCC1
ERCC4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy.PMID 24318989Read ↗

Study on the ERCC1 gene polymorphism response to chemotherapy and prognosis of gastric cancer.Semantic proximity Read ↗

Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer in a Chinese population.Semantic proximity Read ↗

Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer.Semantic proximity Read ↗

Genetic variability of DNA repair mechanisms in chemotherapy treatment outcome of gastric cancer patients.Semantic proximity Read ↗

Genetic variability of DNA repair mechanisms influences chemotherapy outcome of gastric cancer.Semantic proximity Read ↗

Genetic polymorphisms of DNA repair pathways influence the response to chemotherapy and overall survival of gastric cancer.Semantic proximity Read ↗

ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis.Semantic proximity Read ↗

Role of common ERCC1 polymorphisms in cisplatin-resistant epithelial ovarian cancer patients: A study in Chinese cohort.Semantic proximity Read ↗

Effect of ERCC1 polymorphism on the response to chemotherapy and clinical outcome of non-small cell lung cancer.Semantic proximity Read ↗

Functional genetic variants of XRCC4 and ERCC1 predict survival of gastric cancer patients treated with chemotherapy by regulating the gene expression.Semantic proximity Read ↗

Effect of ERCC1 polymorphisms on the response to platinum-based chemotherapy: A systematic review and meta-analysis based on Asian population.Semantic proximity Read ↗

Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survivalSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.